Retroperitoneal fibrosis

Last updated
Retroperitoneal fibrosis
Other namesOrmond's disease
Specialty Rheumatology, vascular surgery, urology
Risk factors male sex, age [1]

Retroperitoneal fibrosis or Ormond's disease is a disease featuring the proliferation of fibrous tissue in the retroperitoneum, the compartment of the body containing the kidneys, aorta, renal tract, and various other structures. It may present with lower back pain, kidney failure, hypertension, deep vein thrombosis, and other obstructive symptoms. It is named after John Kelso Ormond, who rediscovered the condition in 1948. [2] [3] [4]

Contents

Causes

The association of idiopathic retroperitoneal fibrosis with various immune-related conditions and response to immunosuppression led to a search for an autoimmune cause of idiopathic RPF. [5] [6] Many of these previously idiopathic cases can now be attributed to IgG4-related disease, an autoimmune disorder proposed in 2003. [7] [8] [9] Otherwise, one-third of cases are secondary to malignancy, medication (methysergide, hydralazine, beta blockers), prior radiotherapy, or certain infections. [1] [9]

Other associations include:

Diagnosis

The diagnosis of retroperitoneal fibrosis cannot be made on the basis of the results of laboratory studies. CT is the best diagnostic modality: [24] a confluent mass surrounding the aorta [6] and common iliac arteries can be seen. On MRI, it has low T1 signal intensity and variable T2 signal. Malignant retroperitoneal fibrosis usually gives uneven MRI signals, is bulky, extends above the origins of renal arteries, or displaces the aorta anteriorly. Additionally, malignant retroperitoneal fibrosis less frequently displaces the ureters medially when compared to other causes of retroperitoneal fibrosis. [13]

On fludeoxyglucose (18F) (FDG) positron emission tomography (PET) scan, FDG accumulation is shown in the affected area. [13]

Although biopsy is not usually recommended, it is appropriate when malignancy or infection is suspected. Biopsy should also be done if the location of fibrosis is atypical or if there is an inadequate response to initial treatment. [6]

Treatment

In the absence of severe urinary tract obstruction (which generally requires surgery with omental wrapping), treatment is generally with glucocorticoids initially, followed by DMARDs either as steroid-sparing agents or if refractory on steroids. [1] The selective estrogen receptor modulator tamoxifen has shown to improve the condition in various small trials, although the exact mechanism of its action remains unclear. [25]

Related Research Articles

<span class="mw-page-title-main">Abdominal pain</span> Stomach aches

Abdominal pain, also known as a stomach ache, is a symptom associated with both non-serious and serious medical issues.

<span class="mw-page-title-main">Autoimmune hepatitis</span> Chronic, autoimmune disease of the liver

Autoimmune hepatitis, formerly known as lupoid hepatitis, plasma cell hepatitis, or autoimmune chronic active hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells, causing the liver to be inflamed. Common initial symptoms may include fatigue, nausea, muscle aches, or weight loss or signs of acute liver inflammation including fever, jaundice, and right upper quadrant abdominal pain. Individuals with autoimmune hepatitis often have no initial symptoms and the disease may be detected by abnormal liver function tests and increased protein levels during routine bloodwork or the observation of an abnormal-looking liver during abdominal surgery.

<span class="mw-page-title-main">Biliary atresia</span> Medical condition

Biliary atresia, also known as extrahepatic ductopenia and progressive obliterative cholangiopathy, is a childhood disease of the liver in which one or more bile ducts are abnormally narrow, blocked, or absent. It can be congenital or acquired. It has an incidence of one in 10,000–15,000 live births in the United States, and a prevalence of one in 16,700 in the British Isles. Biliary atresia is most common in East Asia, with a frequency of one in 5,000.

<span class="mw-page-title-main">Primary biliary cholangitis</span> Autoimmune disease of the liver

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis. Further slow damage to the liver tissue can lead to scarring, fibrosis, and eventually cirrhosis.

<span class="mw-page-title-main">Aortic aneurysm</span> Excessive enlargement of the human aorta

An aortic aneurysm is an enlargement (dilatation) of the aorta to greater than 1.5 times normal size. They usually cause no symptoms except when ruptured. Occasionally, there may be abdominal, back, or leg pain. The prevalence of abdominal aortic aneurysm ("AAA") has been reported to range from 2 to 12% and is found in about 8% of men more than 65 years of age. The mortality rate attributable to AAA is about 15,000 per year in the United States and 6,000 to 8,000 per year in the United Kingdom and Ireland. Between 2001 and 2006, there were approximately 230,000 AAA surgical repairs performed on Medicare patients in the United States.

<span class="mw-page-title-main">Abdominal aortic aneurysm</span> Medical condition

Abdominal aortic aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than normal. An AAA usually causes no symptoms, except during rupture. Occasionally, abdominal, back, or leg pain may occur. Large aneurysms can sometimes be felt by pushing on the abdomen. Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death.

<span class="mw-page-title-main">Primary sclerosing cholangitis</span> Medical condition

Primary sclerosing cholangitis (PSC) is a long-term progressive disease of the liver and gallbladder characterized by inflammation and scarring of the bile ducts, which normally allow bile to drain from the gallbladder. Affected individuals may have no symptoms or may experience signs and symptoms of liver disease, such as yellow discoloration of the skin and eyes, itching, and abdominal pain.

<span class="mw-page-title-main">Chronic pancreatitis</span> Medical condition

Chronic pancreatitis is a long-standing inflammation of the pancreas that alters the organ's normal structure and functions. It can present as episodes of acute inflammation in a previously injured pancreas, or as chronic damage with persistent pain or malabsorption. It is a disease process characterized by irreversible damage to the pancreas as distinct from reversible changes in acute pancreatitis.

Autoimmune Pancreatitis (AIP) is an increasingly recognized type of chronic pancreatitis that can be difficult to distinguish from pancreatic carcinoma but which responds to treatment with corticosteroids, particularly prednisone. Although autoimmune pancreatitis is quite rare, it constitutes an important clinical problem for both patients and their clinicians: the disease commonly presents itself as a tumorous mass which is diagnostically indistinguishable from pancreatic cancer, a disease that is much more common in addition to being very dangerous. Hence, some patients undergo pancreatic surgery, which is associated to substantial mortality and morbidity, out of the fear by patients and clinicians to undertreat a malignancy. However, surgery is not a good treatment for this condition as AIP responds well to immunosuppressive treatment. There are two categories of AIP: Type 1 and Type 2, each with distinct clinical profiles.

<span class="mw-page-title-main">Syphilitic aortitis</span> Inflammation of the aorta

Syphilitic aortitis is inflammation of the aorta associated with the tertiary stage of syphilis infection. SA begins as inflammation of the outermost layer of the blood vessel, including the blood vessels that supply the aorta itself with blood, the vasa vasorum. As SA worsens, the vasa vasorum undergo hyperplastic thickening of their walls thereby restricting blood flow and causing ischemia of the outer two-thirds of the aortic wall. Starved for oxygen and nutrients, elastic fibers become patchy and smooth muscle cells die. If the disease progresses, syphilitic aortitis leads to an aortic aneurysm. Overall, tertiary syphilis is a rare cause of aortic aneurysms. Syphilitic aortitis has become rare in the developed world with the advent of penicillin treatments after World War II.

Aortitis is the inflammation of the aortic wall. The disorder is potentially life-threatening and rare. It is reported that there are only 1–3 new cases of aortitis per year per million people in the United States and Europe. Aortitis is most common in people 10 to 40 years of age.

<span class="mw-page-title-main">Multifocal fibrosclerosis</span> Medical condition

Multifocal fibrosclerosis and idiopathic fibrosclerosis are disorders of unknown aetiology, characterised by fibrous lesions (co-)occurring at a variety of sites. Known manifestations include retroperitoneal fibrosis, mediastinal fibrosis and Riedel's thyroiditis.

<span class="mw-page-title-main">Idiopathic sclerosing mesenteritis</span> Medical condition

Idiopathic sclerosing mesenteritis (ISM) is a rare disease of the small intestine, characterized by chronic inflammation and eventual fibrosis of the mesentery. It has also been called mesenteric lipodystrophy, or retractile mesenteritis.

<span class="mw-page-title-main">IgG4-related disease</span> Medical condition

IgG4-related disease (IgG4-RD), formerly known as IgG4-related systemic disease, is a chronic inflammatory condition characterized by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, various degrees of fibrosis (scarring) and a usually prompt response to oral steroids. In approximately 51–70% of people with this disease, serum IgG4 concentrations are elevated during an acute phase.

<span class="mw-page-title-main">John Kelso Ormond</span> American urologist

John Kelso Ormond was an American urologist who rediscovered retroperitoneal fibrosis

Chronic sclerosing sialadenitis is a chronic (long-lasting) inflammatory condition affecting the salivary gland. Relatively rare in occurrence, this condition is benign, but presents as hard, indurated and enlarged masses that are clinically indistinguishable from salivary gland neoplasms or tumors. It is now regarded as a manifestation of IgG4-related disease.

<span class="mw-page-title-main">Open aortic surgery</span> Surgical technique

Open aortic surgery (OAS), also known as open aortic repair (OAR), describes a technique whereby an abdominal, thoracic or retroperitoneal surgical incision is used to visualize and control the aorta for purposes of treatment, usually by the replacement of the affected segment with a prosthetic graft. OAS is used to treat aneurysms of the abdominal and thoracic aorta, aortic dissection, acute aortic syndrome, and aortic ruptures. Aortobifemoral bypass is also used to treat atherosclerotic disease of the abdominal aorta below the level of the renal arteries. In 2003, OAS was surpassed by endovascular aneurysm repair (EVAR) as the most common technique for repairing abdominal aortic aneurysms in the United States.

<span class="mw-page-title-main">IgG4-related prostatitis</span> Medical condition

IgG4-related prostatitis is prostate involvement in men with IgG4-related disease (IgG4-RD), which is an emerging fibroinflammatory disease entity which is characterised (i) by a tendency to mass forming lesions in multiple sites of the body and (ii) by usually a prompt response to steroid therapy.

<span class="mw-page-title-main">Inflammatory aortic aneurysm</span> Medical condition

Inflammatory aortic aneurysm (IAA), also known as Inflammatory abdominal aortic aneurysm (IAAA), is a type of abdominal aortic aneurysm (AAA) where the walls of the aneurysm become thick and inflamed. Similar to AAA, IAA occurs in the abdominal region. IAA is closely associated and believed to be a response to and extensive peri-aneurysmal fibrosis, which is the formation of excess fibrous connective tissue in an organ or tissue in a reparative or reactive process IAA accounts for 5-10% of aortic aneurysms. IAA occurs mainly in a population that is on average younger by 10 years than most AAA patients. Some common symptoms of IAA may include back pain, abdominal tenderness, fevers, weight loss or elevated Erythrocyte sedimentation rate (ESR) levels. Corticosteroids and other immunosuppressive drugs have been found to decrease symptoms and the degree of peri-aortic inflammation and fibrosis

<span class="mw-page-title-main">IgG4-related ophthalmic disease</span> Medical condition

IgG4-related ophthalmic disease (IgG4-ROD) is the recommended term to describe orbital manifestations of the systemic condition IgG4-related disease, which is characterised by infiltration of lymphocytes and plasma cells and subsequent fibrosis in involved structures. It can involve one or more of the orbital structures.

References

  1. 1 2 3 van Bommel EF (July 2002). "Retroperitoneal fibrosis". Neth J Med. 60 (6): 231–42. PMID   12365466 . Retrieved 10 August 2022.
  2. ↑ Albarran-Ormond syndrome at Who Named It?
  3. ↑ Ormond JK (1948). "Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process". J. Urol. 59 (6): 1072–9. doi:10.1016/s0022-5347(17)69482-5. PMID   18858051.
  4. ↑ Ormond JK (October 1965). "Idiopathic retroperitoneal fibrosis: a discussion of the etiology". J. Urol. 94 (4): 385–90. doi:10.1016/s0022-5347(17)63635-8. PMID   5839568.
  5. ↑ Thongprayoon, C; Spanuchart I; Cheungpasitporn W; Kangwanpornsiri A (May 2014). "Idiopathic retroperitoneal fibrosis: a challenging case in a rare disease". N Am J Med Sci. 6 (5): 237–8. doi: 10.4103/1947-2714.132945 . PMC   4049060 . PMID   24926452.
  6. 1 2 3 Vaglio A, Salvarani C, Buzio C (January 2006). "Retroperitoneal fibrosis". Lancet. 367 (9506): 241–51. doi:10.1016/S0140-6736(06)68035-5. PMID   16427494. S2CID   25511135.
  7. ↑ Kamisawa, Terumi; Egawa, Naoto; Nakajima, Hitoshi (2003). "Autoimmune Pancreatitis is a Systemic Autoimmune Disease". American Journal of Gastroenterology. 98 (12): 2811–2812. doi:10.1111/j.1572-0241.2003.08758.x. PMID   14687846. S2CID   36222260.
  8. ↑ Lanzillotta, Marco; Mancuso, Gaia; Della-Torre, Emmanuel (2020). "Advances in the diagnosis and management of IgG4 related disease". The British Medical Journal. 369: m1067. doi: 10.1136/bmj.m1067 . PMID   32546500. m1067.
  9. 1 2 Lian, Linjuan; Wang, Cong; Tian, Jian-li (2016). "IgG4-related retroperitoneal fibrosis: A newly characterized disease". International Journal of Rheumatic Diseases. 19 (11): 1049–1055. doi: 10.1111/1756-185X.12863 . PMID   27125330.
  10. ↑ Dhanawat, Aditya; Gupta, Partisha; Padhan, Prasanta (2020). "Mixed Connective Tissue Disease with Retroperitoneal Fibrosis: A Rare Occurrence". Archives of Rheumatology. 35 (1): 137–141. doi: 10.5606/ArchRheumatol.2020.7452 . PMC   7322295 . PMID   32637930.
  11. 1 2 Biyani, Chandra Shekhar; Taylor, Joby; Browning, Anthony J. (2 September 2021). Schwartz, Bradley Fields (ed.). "Retroperitoneal Fibrosis Overview". Medscape. Retrieved 10 August 2022.
  12. ↑ Drieskens, Oliver; Blockmans, Daniel; Van den Bruel, Annick; Mortelmans, Luc (2002). "Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: Positron emission tomographic findings". Clinical Nuclear Medicine. 27 (6): 413–415. doi:10.1097/00003072-200206000-00005. PMID   12045432. S2CID   423062.
  13. 1 2 3 4 Vaglio, Augusto; Maritati, Federica (July 2016). "Idiopathic Retroperitoneal Fibrosis". Journal of the American Society of Nephrology. 27 (7): 1880–1889. doi:10.1681/ASN.2015101110. ISSN   1046-6673. PMC   4926988 . PMID   26860343.
  14. ↑ LeBlanc, Claire M.A.; Inman, Robert D.; Dent, Peter; Smith, Charles; Babyn, Paul; Laxer, Ronald M. (2002). "Retroperitoneal Fibrosis: An Extraarticular Manifestation of Ankylosing Spondylitis". Arthritis & Rheumatism (Arthritis Care & Research). 42 (2): 210–214. doi: 10.1002/art.10267 . PMID   11954016.
  15. ↑ Kermani, Tanaz A.; Crowson, Cynthia S.; Achenbach, Sara J.; Luthra, Harvinder S. (2011). "Idiopathic Retroperitoneal Fibrosis: A Retrospective Review of Clinical Presentation, Treatment, and Outcomes". Mayo Clinic Proceedings. 86 (4): 297–303. doi: 10.4065/mcp.2010.0663 . PMC   3068889 . PMID   21454732.
  16. ↑ Fanidou, Domna; Filippou, Nikolaos; Katseli, Anastasia; Papadopoulos, Georgios; Skandalakis, Panagiotis; Filippou, Dimitrios (2018). "Autoimmune pancreatitis associated with retroperitoneal fibrosis mimicking cholangiocarcinoma". Oxford Medical Case Reports. 2018 (9): omy056. doi: 10.1093/omcr/omy056 . PMC   6109199 . PMID   30159151.
  17. ↑ Fukukura, Yoshihiko; Fujiyoshi, Fumito; Nakamura, Fumihiko; Hamada, Hiroyuki; Nakajo, Masayuki (2003). "Autoimmune Pancreatitis Associated with Idiopathic Retroperitoneal Fibrosis". American Journal of Roentgenology (PDF). 181 (4): 993–995. doi:10.2214/ajr.181.4.1810993. PMID   14500215 . Retrieved 10 August 2022.
  18. ↑ Kamisawa, Terumi; Chen, Pong-Yui; Tu, Yuyang; Nakajima, Hitoshi; Egawa, Naoto (2006). "Autoimmune pancreatitis metachronously associated with retroperitoneal fibrosis with IgG4-positive plasma cell infiltration". World Journal of Gastroenterology. 12 (18): 2955–2957. doi: 10.3748/wjg.v12.i18.2955 . PMC   4087819 . PMID   16718827.
  19. ↑ Tatari, Murat; Trujillo, David Abia; Mira-Avendano, Isabel (October 2020). "Retroperitoneal Fibrosis Presenting as Ureteral Obstruction Secondary to Sarcoidosis". Chest. 158 (4): A1200. doi: 10.1016/j.chest.2020.08.1093 . S2CID   225126556. A1200.
  20. ↑ Huang, Xuan; Lu, Bin; Li, Meng; Fan, Yihong; Zhang, Lu (2018). "IgG4-related retroperitoneal fibrosis overlapping with primary biliary cirrhosis and primary Sjögren's syndrome: A case report". Medicine. 97 (26): e11303. doi: 10.1097/MD.0000000000011303 . PMC   6039603 . PMID   29953016. e11303.
  21. ↑ Sevenet, François; Capron-Chivrac, Dominique; Delcenserie, Richard; Lelarge, Christian; Delamarre, Jacques; Capron, Jean-Pierre (1985). "Idiopathic Retroperitoneal Fibrosis and Primary Biliary Cirrhosis: A New Association?". Archives of Internal Medicine. 145 (11): 2124–2125. doi:10.1001/archinte.1985.00360110200042. PMID   4062468.
  22. ↑ Poredos, Pavel (2008). "Inflammatory aortic aneurysm". e-Journal of the European Society for Cardiology Practice. 7 (10). Retrieved 10 August 2022.
  23. ↑ Fatima, Javairiah; Gota, Carmen; Clair, Daniel G.; Billings, Steven D.; Gornik, Heather L. (2014). "Inflammatory Abdominal Aortic Aneurysm with Retroperitoneal Fibrosis". Circulation. 130 (15): 1300–1302. doi: 10.1161/CIRCULATIONAHA.114.010173 . PMID   25287771.
  24. ↑ Avaria P, Hirsch M.Forniceal rupture and urinoma secondary to retroperitoneal fibrosis: A clinical case and literature review. https://doi.org/10.1016/j.uromx.2015.10.001
  25. ↑ Biyani, Chandra Shekhar; Taylor, Joby; Browning, Anthony J. (2 September 2021). Schwartz, Bradley Fields (ed.). "Retroperitoneal Fibrosis Treatment & Management". Medscape. Retrieved 10 August 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.